Nomogram for visual acuity outcome after iodine-125 plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma in 1131 patients.
CONCLUSIONS: A nomogram using clinical or treatment risk factors can predict visual acuity outcome following plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma and is available online at https://fighteyecancer.com/nomograms/.
PMID: 31409650 [PubMed - as supplied by publisher]
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Dalvin LA, Zhang Q, Hamershock RA, Chang M, Yu MD, Mashayekhi A, Shields CL Tags: Br J Ophthalmol Source Type: research
More News: Avastin | Diabetes | Endocrinology | Eye Cancers | Insulin | Iodine | Melanoma | Mushrooms | Opthalmology | Skin Cancer | UK Health | Uveal Melanoma